NCT06469164 - A First-in-human Safety Trial of BNT331 Administered as Single Ascending Doses in Healthy Women and as Multiple Ascending Doses in Women Diagnosed With Bacterial Vaginosis | Biotech Hunter

Enrollment

102

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions

Bacterial Vaginosis

Interventions

DRUG

BNT331

Vaginal insert

OTHER

Placebo

Vaginal insert

Trial Locations (6)

Chattanooga Medical Research, LLC, Chattanooga

Nucleus Network, Saint Paul

Southern Clinical Research Associates - Metairie, Metairie

Praetorian Pharmaceutical Research, LLC, Marrero

Women Under Study, LLC, New Orleans

UAB Sexual Health Research Clinic, Birmingham